Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 21002-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- OTUD5 antibody
- Antibody type
- Polyclonal
- Description
- OTUD5 antibody (Cat. #21002-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury.
USP11 Exacerbates Radiation-Induced Pneumonitis by Activating Endothelial Cell Inflammatory Response via OTUD5-STING Signaling.
CacyBP promotes the development of lung adenocarcinoma by regulating OTUD5.
Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression.
Zhao Y, Fan S, Zhu H, Zhao Q, Fang Z, Xu D, Lin W, Lin L, Hu X, Wu G, Min J, Liang G
Nature communications 2024 Jun 27;15(1):5441
Nature communications 2024 Jun 27;15(1):5441
USP11 Exacerbates Radiation-Induced Pneumonitis by Activating Endothelial Cell Inflammatory Response via OTUD5-STING Signaling.
Tang Y, Wang T, Gu L, Xu Y, Yang Z, Zhu W, Zhang Q, Luo J, Cao J, Jiao Y
International journal of radiation oncology, biology, physics 2024 Jul 15;119(4):1261-1274
International journal of radiation oncology, biology, physics 2024 Jul 15;119(4):1261-1274
CacyBP promotes the development of lung adenocarcinoma by regulating OTUD5.
Bai M, Lu K, Che Y, Fu L
Carcinogenesis 2024 Aug 12;45(8):595-606
Carcinogenesis 2024 Aug 12;45(8):595-606
Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression.
Liu Q, Luo Q, Feng J, Zhao Y, Ma B, Cheng H, Zhao T, Lei H, Mu C, Chen L, Meng Y, Zhang J, Long Y, Su J, Chen G, Li Y, Hu G, Liao X, Chen Q, Zhu Y
eLife 2022 Aug 1;11
eLife 2022 Aug 1;11
No comments: Submit comment
No validations: Submit validation data